External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home COMy 2025
Roche and Genentech at

COMy 2025

May 15 - May 18
Paris, France / Virtual (Hybrid)
comy.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
09:40 AM
Duration 10mins Online - Multiple Myeloma Communications Sessions
Cevostamab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma: updated Phase I safety run-in results from the CAMMA 1 study
Spencer A, Mian HS, Harrison SJ, Vij R, Mihalyova J, Lavi N, Kim K, Szarejko M, Tyagi T, Uguen M, Mishra A, Sewpaul P, Richardson L, Trudel S
Haematology | Hematologic Diseases

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.